News
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Medicare is barred under a 2003 law from paying for weight-loss medications like Wegovy. Lawmakers on Thursday reintroduced a bill that would expand Medicare coverage to the drugs.
New weight-loss drugs are out of reach for millions of older Americans because Medicare won’t pay Debra Tyler’s daughter takes her new medication at home in Killingworth, Conn.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results